BIRB-796 is not an effective ABL(T315I) inhibitor [1] (multiple letters)

Thomas O'Hare, Brian J. Druker, Miles A. Fabian, William H. Biggs, Daniel K. Treiber, Patrick P. Zarrinkar, David J. Lockhart

Research output: Contribution to journalLetter

15 Scopus citations
Original languageEnglish (US)
Pages (from-to)1209-1211
Number of pages3
JournalNature biotechnology
Volume23
Issue number10
DOIs
StatePublished - Oct 1 2005

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology
  • Molecular Medicine
  • Biomedical Engineering

Cite this

O'Hare, T., Druker, B. J., Fabian, M. A., Biggs, W. H., Treiber, D. K., Zarrinkar, P. P., & Lockhart, D. J. (2005). BIRB-796 is not an effective ABL(T315I) inhibitor [1] (multiple letters). Nature biotechnology, 23(10), 1209-1211. https://doi.org/10.1038/nbt1005-1209